ANDREA HARRISON: Open Payments
NPI 1417649062 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,438 in 129 payments from 16 companies in 2025. Trend: 2023 $725 · 2024 $2,908 · 2025 $2,438
Food & beverage: $2,361Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 23 | $601 |
| ABBVIE INC. | 41 | $527 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $257 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $224 |
| Gilead Sciences, Inc. | 7 | $158 |
| Lilly USA, LLC | 8 | $139 |
| Madrigal Pharmaceuticals | 6 | $137 |
| Regeneron Healthcare Solutions, Inc. | 3 | $86 |
| GENZYME CORPORATION | 3 | $80 |
| PFIZER INC. | 4 | $77 |
Products named: TREMFYA, RINVOQ, ENTYVIO, XIFAXAN, DUPIXENT, REZDIFFRA, OMVOH, XELJANZ.
Industry payments across KY — which companies pay providers there.
